Observational studyBMC pulmonary medicine2021

Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study).

Eva Martínez-Moragón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.